Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP4F2 | P78329 | 1/20 | 0.37 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.37 |
| ▸ | SERPINE1 | P05121 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | HMGCR | P04035 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13857979 | 0.87 | CYP4F2 (0.39) | CYP4F2CYP4A11SERPINE1LMNAHSD17B10 | |
| SCHEMBL9924517 | 0.85 | CYP4F2 (0.34) | CYP4F2CYP4A11SERPINE1HMGCR | |
| SCHEMBL130762 | 0.84 | CYP4F2 (0.38) | CYP4F2CYP4A11LMNAHSD17B10HMGCR | |
| SCHEMBL21284569 | 0.84 | CYP4F2 (0.38) | CYP4F2CYP4A11LMNAHSD17B10HMGCR | |
| SCHEMBL13686650 | 0.84 | PRKCA (0.39) | CYP4F2CYP4A11SERPINE1LMNAHSD17B10 | |
| SCHEMBL12326378 | 0.82 | CYP4F2 (0.33) | CYP4F2CYP4A11SERPINE1HMGCR | |
| SCHEMBL6368436 | 0.82 | CYP4F2 (0.37) | CYP4F2CYP4A11LMNAHSD17B10HMGCR | |
| SCHEMBL12858522 | 0.81 | CYP4F2 (0.32) | CYP4F2CYP4A11 | |
| SCHEMBL2735475 | 0.80 | CYP4F2 (0.36) | CYP4F2CYP4A11LMNAHSD17B10HMGCR | |
| SCHEMBL20747687 | 0.80 | LMNA (0.35) | SERPINE1LMNAHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100143274-A1 | USE OF AMINES AND AMIDES FOR THE STABILIZATION OF ORGANIC MICRONIZED UV ABSORBERS | CIBA CORPORATION (US) | 2010-06-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100143274-A1 | USE OF AMINES AND AMIDES FOR THE STABILIZATION OF ORGANIC MICRONIZED UV ABSORBERS | MAOA, MAOB, ACMSD | CYP4F2 894/4885CYP4A11 677/4885SERPINE1 2091/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.